Kinetics of maternal antibodies against rubella and varicella in infants
- PMID: 20558248
- DOI: 10.1016/j.vaccine.2010.06.004
Kinetics of maternal antibodies against rubella and varicella in infants
Abstract
Kinetics of maternal rubella and varicella antibodies in 213 mother-infant pairs are described in a longitudinal study in Belgium. Blood samples are taken at 7 time points (week 36 of pregnancy, birth (cord), 1, 3, 6, 9, and 12 months), and analyzed for anti-rubella IgG and anti-varicella IgG by enzyme linked immunosorbent assay (ELISA). A generalized exponential model is used to analyse maternal antibody decay in infants. Model based, the mean duration of passive immunity is 2.1 months for rubella and 2.4 months for varicella. Infants are susceptible at young age for rubella, a disease with high vaccination coverage, as well as for varicella, an endemic disease in Western Europe.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.Vaccine. 2006 Apr 12;24(16):3258-60. doi: 10.1016/j.vaccine.2006.01.026. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16459000
-
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.BMJ. 2010 May 18;340:c1626. doi: 10.1136/bmj.c1626. BMJ. 2010. PMID: 20483946
-
[Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].An Esp Pediatr. 1999 May;50(5):459-62. An Esp Pediatr. 1999. PMID: 10394183 Spanish.
-
[Transplacentally acquired immunoglobulin G antibodies in newborns and infants].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:627-31. Nihon Rinsho. 2007. PMID: 17455693 Review. Japanese. No abstract available.
-
WHO international standard for anti-rubella: learning from its application.Lancet Infect Dis. 2020 Jan;20(1):e17-e19. doi: 10.1016/S1473-3099(19)30274-9. Epub 2019 Sep 6. Lancet Infect Dis. 2020. PMID: 31501007 Review.
Cited by
-
Stakeholders Perspectives on the Introduction of an Additional Injectable Vaccine Under the Universal Immunization Programme in India.Vaccines (Basel). 2025 Mar 20;13(3):334. doi: 10.3390/vaccines13030334. Vaccines (Basel). 2025. PMID: 40266231 Free PMC article.
-
Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies - A Case Report.J Neuromuscul Dis. 2024;11(2):493-498. doi: 10.3233/JND-221659. J Neuromuscul Dis. 2024. PMID: 38306058 Free PMC article.
-
Varicella-Zoster Virus Prevalence among Pregnant Women: A European Epidemiological Review.Life (Basel). 2023 Feb 20;13(2):593. doi: 10.3390/life13020593. Life (Basel). 2023. PMID: 36836948 Free PMC article. Review.
-
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.BMC Infect Dis. 2017 May 18;17(1):353. doi: 10.1186/s12879-017-2445-2. BMC Infect Dis. 2017. PMID: 28521810 Free PMC article.
-
Limited Neonatal Carbohydrate-Specific Antibody Repertoire Consecutive to Partial Prenatal Transfer of Maternal Antibodies.Front Immunol. 2020 Oct 14;11:573629. doi: 10.3389/fimmu.2020.573629. eCollection 2020. Front Immunol. 2020. PMID: 33162988 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical